SWOG clinical trial number
SWOG-8017

5-FU, Adriamycin, Streptozotocin and Cyclophosphamide (FAC-S) in the Treatment of Metastatic Carcinoid Tumors

Closed
Phase
II
Published
Abbreviated Title
5-FU, Adriamycin, Streptozotocin and Cyclophosphamide (FAC-S) in the Treatment of Metastatic Carcinoid Tumors
Activated
07/07/1980
Closed
01/19/1984

Publication Information Expand/Collapse

1987

A phase II trial of combination chemotherapy in patients withmetastatic carcinoid tumors: A Southwest Oncology Group Study.

RM Bukowski;KG Johnson;RF Peterson;RL Stephens;SE Rivkin;B Neilan;JJ Costanzi Cancer 60:2891-2895

1983

Phase II trial of 5FU, Adriamycin, Cyclophosphamide, and Streptozotocin (FAC-S) in metastatic carcinoid (for the Southwest Oncology Group).

RM Bukowski;R Stephens;N Oishi;R Petersen;T Chen ASCO #C-510